Wednesday, February 19, 2014

Neurology

Antidepressant holds promise in treating Alzheimer's agitation
The antidepressant citalopram, sold under the brand names Celexa and Cipramil, significantly relieved agitation in a group of Alzheimer's disease (AD) patients as reported in the February 19 issue of the Journal of the American Medical Association. Eurekalert!

Could metabolism play a role in epilepsy?
Researchers from the Franciscan University of Steubenville, Ohio are exploring a possible link between metabolic defects and seizures. They determined that diet could influence susceptibility to seizures, and they have identified a common diabetes drug that could be useful in treating disorders such as epilepsy. JoVE

Neuropsychological assessment more efficient than MRI for tracking disease progression
Investigators at the University of Amsterdam, The Netherlands, have shown that progression of disease in memory clinic patients can be tracked efficiently with 45 minutes of neuropsychological testing. MRI measures of brain atrophy were shown to be less reliable to pick up changes in the same patients. Eurekalert!

No comments:

Post a Comment